ru24.pro
News in English
Сентябрь
2024

Новости за 17.09.2024

Comparison of No-Test Telehealth and In-Person Medication Abortion

Jamanetwork.com 

This prospective, observational study investigates the efficacy and safety of medication abortion provided using no-test telehealth eligibility screening and mailing of medications compared with in-person care with ultrasonography in the US.

Modern Strategies for Smallpox Readiness

Jamanetwork.com 

This Viewpoint highlights the potential for unintentional or deliberate release of variola virus (smallpox), discusses current medical countermeasures for smallpox, and calls for greater flexibility from the US and its partners in developing safe, reliable, affordable, and equitable countermeasures.

Risankizumab for Ulcerative Colitis

Jamanetwork.com 

These 2 randomized clinical trials compare the efficacy and safety of risankizumab vs placebo during an induction trial and a maintenance trial in patients with ulcerative colitis.

Monoclonal Antibody Risankizumab for Ulcerative Colitis

Jamanetwork.com 

The inflammatory bowel diseases of ulcerative colitis and Crohn disease are chronic inflammatory conditions of the intestine. The estimated incidence of ulcerative colitis is 15 per 100 000 person-years and the prevalence is 400 per 100 000 in North America. Despite advances to medical management, nearly 1 in 5 patients with ulcerative colitis will be hospitalized and approximately 7% will require a colectomy within 5 years of diagnosis. The health care cost of ulcerative colitis has steadily risen over the past 2 decades... Читать дальше...

History Repeats—The Election Battle for Medicaid in 2024

Jamanetwork.com 

This Viewpoint explores partisan attitudes toward Medicaid in the 2024 US election and the implications for access to care and health equity if a Republican proposal that includes work requirements and block grants moves forward.

Data Clarification

Jamanetwork.com 

In the Medical News in Brief article titled “Adding Salt to Food at Mealtime Associated With Stomach Cancer Risk,” published on July 2, 2024, the absolute risk of cancer among those who salt their meals at the table was omitted. This article was corrected online.

Bleeding in Patients With Atrial Fibrillation—Reply

Jamanetwork.com 

In Reply Although the available data suggest that, in patients with atrial fibrillation, sex is not associated with serious oral anticoagulant-related bleeding, as suggested by Dr Samuelson Bannow and colleagues, we analyzed the interaction between diltiazem and apixaban/rivaroxaban according to sex. The cohort included 107 652 females with a mean age of 77.8 (SD, 7.2) years and 96 503 males with a mean age of 75.9 (SD, 6.6) years. The outcome was the composite of bleeding-related hospitalization or death with recent evidence of bleeding... Читать дальше...

Bleeding in Patients With Atrial Fibrillation

Jamanetwork.com 

To the Editor A recent study reported a higher incidence of serious bleeding in patients using diltiazem, compared with metoprolol, in conjunction with apixaban or rivaroxaban for the treatment of atrial fibrillation. The authors also reported a higher proportion of women in the diltiazem group (59.3% vs 50.4%). We read this study with particular interest given postmarketing data on uterine bleeding in women taking various direct oral anticoagulants, with rates of abnormal uterine bleeding as high as 67%. Читать дальше...

USPSTF Recommendation: Iron Deficiency During Pregnancy

Jamanetwork.com 

This 2024 Recommendation Statement from the US Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of screening and routine supplementation for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes (I statement).

Iron Deficiency Anemia in Pregnancy

Jamanetwork.com 

The US Preventive Services Task Force (USPSTF) recently released a Recommendation Statement examining the data to support screening for iron deficiency anemia in pregnancy and finding them lacking. It also found insufficient evidence to make a clear recommendation for or against preventive iron supplementation in pregnancy, which has been a routine practice for decades, with up to 77% to 89% of patients reporting supplement use. As highlighted previously by the USPSTF and others, there is an urgent... Читать дальше...

Change to Nonauthor Collaborator Name

Jamanetwork.com 

The Original Investigation titled “Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial,” published on April 11, 2023, has been updated to fix the name of Matteo Aldo Bonizzoni in a supplement. This article was corrected online.

Revision of Name in List of Nonauthor Collaborators

Jamanetwork.com 

The Original Investigation titled “Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials,” published on November 14, 2023, has been updated to fix the name of Matteo Aldo Bonizzoni in a supplement. This article was corrected online.

Rosebud

Jamanetwork.com 

I saw an aged woman adorned by those she loved and my heart wondered. She couldn’t tell if she was dying or perhaps had died already but she knew about journeys— that we are only borne far by those we hold.

Surrogate Markers and Clinical Outcomes—Reply

Jamanetwork.com 

In Reply Dr Siegel and colleagues at the FDA raise concerns that our article incorrectly indicated that the FDA relies only on meta-analyses to establish surrogacy and “incorrectly identifies the evidence the FDA used to conclude that these biomarkers can serve as surrogate end points.” However, nowhere in the article did we state that the FDA relies only on meta-analyses to establish the surrogacy of a biomarker for a clinical outcome.